Holen Sie sich die Stockscreener-App
30.30
2.05%
-0.635
Xoma Royalty Corp Aktie (XOMA) Neueste Nachrichten
XOMA Royalty completes acquisition of Mural Oncology for $2.035 per share - Investing.com Canada
XOMA Royalty Announces Closing of Transaction to Acquire Mural Oncology plc - Yahoo Finance
XOMA Royalty completes acquisition of Mural Oncology - Investing.com
Mural Oncology plc Announces Effective Date of Scheme Arrangement for Acquisition by XOMA Royalty Corporation - Quiver Quantitative
Mural Oncology (Nasdaq: MURA) scheme with XOMA unit effective as Nasdaq listing ends - Stock Titan
Why XOMA Royalty Corporation (X0M1) stock could be top winnerJuly 2025 Outlook & Weekly High Return Stock Opportunities - Newser
Will XOMA Royalty Corporation (X0M1) stock test record highs in 20252025 Price Action Summary & Weekly High Return Forecasts - Newser
Why XOMA Royalty Corporation (X0M1) stock appeals to dividend investorsEarnings Recap Report & Capital Efficient Trade Techniques - Newser
What earnings margins imply for XOMA Royalty Corporation(X0M) stockIPO Watch & Risk Managed Investment Strategies - Newser
Irish court approves XOMA Royalty’s acquisition of Mural Oncology By Investing.com - Investing.com India
Mural Oncology Announces Sanction of the Scheme by the High Court - The Manila Times
Mural Oncology plc Announces Court Approval of Scheme for Acquisition by XOMA Royalty Corporation's Subsidiary - Quiver Quantitative
Mural Oncology Announces Sanction of the Scheme by the High Court - Benzinga
Is XOMA Royalty Corporation (X0M1) stock a defensive play amid uncertaintyMarket Activity Summary & Weekly Watchlist for Consistent Profits - Newser
How robust is XOMA Royalty Corporation(X0M) stock financial position - Newser
XOMA Royalty (NASDAQ:XOMA) Stock Price Passes Above 200 Day Moving AverageShould You Sell? - MarketBeat
Mural Oncology Shareholders To Receive $2.035 Cash Per Share In XOMA Royalty Acquisition - Nasdaq
XOMA Royalty to acquire Mural Oncology for $2.035 per share By Investing.com - Investing.com Nigeria
XOMA Royalty to acquire Mural Oncology for $2.035 per share - Investing.com India
Mural Oncology announces final cash consideration payable on acquisition close - TipRanks
Mural Oncology plc Announces Final Determination of Additional Price Per Share in Acquisition by XOMA Royalty Corporation - Quiver Quantitative
Mural Oncology Announces Final Cash Consideration Payable on Closing of Acquisition by XOMA Royalty - The Manila Times
Mural Oncology (Nasdaq: MURA) to Be Acquired by XOMA Royalty for $2.035 Cash - Stock Titan
XOMA (NASDAQ:XOMAP) Trading 0.2% Higher – Should You Buy? - Defense World
Xoma completes $24.9M acquisition of cash-strapped Lava Therapeutics - The Business Journals
XOMA Royalty Announces Closing of Transactions to Acquire LAVA Therapeutics N.V. - ADVFN
Xoma announces closing of transactions to acquire Lava Therapeutics - TipRanks
XOMA Royalty completes acquisition of LAVA Therapeutics - Investing.com
[8-K] XOMA Royalty Corp Reports Material Event - Stock Titan
XOMA Royalty completes acquisition of LAVA Therapeutics By Investing.com - Investing.com UK
XOMA Royalty Corporation Completes Acquisition of LAVA Therapeutics N.V. - Quiver Quantitative
XOMA Royalty (Nasdaq: XOMA) completes LAVA deal; investors get $1.04 plus CVR - Stock Titan
symbol__ Stock Quote Price and Forecast - CNN
How XOMA Royalty Corporation (X0M1) stock reacts to Fed tighteningJobs Report & High Accuracy Trade Alerts - newser.com
How XOMA Royalty Corporation stock performs after earningsEarnings Recap Report & Long-Term Safe Investment Ideas - newser.com
How XOMA Royalty Corporation(X0M) stock behaves under inflation pressure2025 Market Sentiment & Risk Adjusted Buy and Sell Alerts - newser.com
Is XOMA Royalty Corporation stock a safe buy before earningsRate Hike & Verified Momentum Stock Watchlist - newser.com
Is XOMA Royalty Corporation (X0M1) stock attractive for dividend growthNew Guidance & High Conviction Investment Ideas - newser.com
Can XOMA Royalty Corporation (X0M1) stock attract analyst upgrades2025 Earnings Impact & Reliable Trade Execution Plans - newser.com
Why XOMA Royalty Corporation stock remains undervaluedJuly 2025 Setups & Technical Confirmation Trade Alerts - newser.com
How XOMA Royalty Corporation stock compares to market leadersTreasury Yields & AI Enhanced Market Trend Forecasts - newser.com
XOMA Royalty's (NASDAQ:XOMA) Earnings Aren't As Good As They Appear - Yahoo Finance
How strong is XOMA Royalty Corporation stock revenue growthEarnings Performance Report & Weekly High Return Stock Opportunities - newser.com
Why millennials buy XOMA Royalty Corporation (X0M1) stock2025 Trading Volume Trends & Free Weekly Chart Analysis and Trade Guides - newser.com
Will XOMA Royalty Corporation stock keep outperforming rivals2025 Short Interest & Fast Gaining Stock Reports - newser.com
XOMAO | XOMA Royalty Corporation Depositary Stock Data, Price & News - Quiver Quantitative
XOMAO Stock Institutional Owners - Quiver Quantitative
LuxembourgXOMA Royalty Acquires LAVA Therapeutics - Mondaq
Xoma turns its attention to Repare | ApexOncoClinical Trials news and analysis - Oncology Pipeline
XOMAP | XOMA Royalty Corporation 8.625% Stock Data, Price & News - Quiver Quantitative
Q4 EPS Estimates for XOMA Royalty Cut by Leerink Partnrs - Defense World
0.40%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):